Trials / Completed
CompletedNCT00461942
Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Neuroprotection Effect of Green Tea Polyphenol in De Novo Parkinson's Disease Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 480 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson's disease Patients without taking any antiparkinsonism drug
Detailed description
The primary outcome measurement is UPDRS using a delay start design. Total 480 de novo PD patients divided into three dosage groups of green tea polyphenol and one placebo control group. Patients will be treated for one year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Green Tea Polyphenols (EGCG/ECG) |
Timeline
- Start date
- 2006-04-01
- Completion
- 2009-03-01
- First posted
- 2007-04-18
- Last updated
- 2011-08-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00461942. Inclusion in this directory is not an endorsement.